000172051 001__ 172051
000172051 005__ 20210129214350.0
000172051 037__ $$aFZJ-2014-05600
000172051 041__ $$aEnglish
000172051 1001_ $$0P:(DE-Juel1)142510$$aBreunig, Katharina$$b0$$eCorresponding Author$$ufzj
000172051 1112_ $$a15th International Workshop on Targetry and Target Chemistry$$cPrag$$d2014-08-18 - 2014-08-21$$wCzech Republic
000172051 245__ $$aProduction of n.c.a. radiobromide: new nickel selenide target and optimized separation by dry distillation
000172051 260__ $$c2014
000172051 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1414997883_19704$$xOther
000172051 3367_ $$033$$2EndNote$$aConference Paper
000172051 3367_ $$2DataCite$$aOther
000172051 3367_ $$2ORCID$$aLECTURE_SPEECH
000172051 3367_ $$2DRIVER$$aconferenceObject
000172051 3367_ $$2BibTeX$$aINPROCEEDINGS
000172051 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000172051 536__ $$0G:(DE-HGF)POF2-89573$$a89573 - Neuroimaging (POF2-89573)$$cPOF2-89573$$fPOF II T$$x1
000172051 7001_ $$0P:(DE-Juel1)131849$$aSpahn, Ingo$$b1$$ufzj
000172051 7001_ $$0P:(DE-Juel1)131850$$aSpellerberg, Stefan$$b2$$ufzj
000172051 7001_ $$0P:(DE-Juel1)131846$$aScholten, Bernhard$$b3$$ufzj
000172051 7001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b4$$ufzj
000172051 773__ $$y2014
000172051 909CO $$ooai:juser.fz-juelich.de:172051$$pVDB
000172051 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)142510$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000172051 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131849$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000172051 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131850$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000172051 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131846$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000172051 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000172051 9132_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bPOF III$$lKey Technologies$$vDecoding the Human Brain$$x0
000172051 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000172051 9131_ $$0G:(DE-HGF)POF2-89573$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vNeuroimaging$$x1
000172051 9141_ $$y2014
000172051 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000172051 980__ $$aconf
000172051 980__ $$aVDB
000172051 980__ $$aI:(DE-Juel1)INM-5-20090406
000172051 980__ $$aUNRESTRICTED